InvestorsHub Logo
Followers 1
Posts 47
Boards Moderated 0
Alias Born 08/02/2017

Re: None

Thursday, 10/29/2020 11:59:44 AM

Thursday, October 29, 2020 11:59:44 AM

Post# of 17421
The company is extremely undervalued at a 2b market cap given the high likelihood that Voclosporin should achieve close to that amount in annual sales. If we consider 3x projected revenue as realistic buyout price we should be valued at around 5-6b. DES isn’t factored into this but could add further value when the buyout happens. Buying the stock now is a no brainer given the incipient approval. The GIA talk is obviously necessary for negotiation purposes but the management team was selected for their expertise in getting the company ready to be sold and this will happen most likely in 2021.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News